Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1080
-
Total 13F shares, excl. options
-
134M
-
Shares change
-
-8.24M
-
Total reported value, excl. options
-
$39.6B
-
Value change
-
-$2.29B
-
Put/Call ratio
-
1.36
-
Number of buys
-
391
-
Number of sells
-
-527
-
Price
-
$296.73
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2019
1,219 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2019.
BIOGEN INC. - Common Stock (BIIB) has 1,080 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134M shares
of 147M outstanding shares and own 90.78% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.2M shares), VANGUARD GROUP INC (13.9M shares), STATE STREET CORP (8.23M shares), Clearbridge Investments, LLC (5.14M shares), WELLINGTON MANAGEMENT GROUP LLP (4.66M shares), RENAISSANCE TECHNOLOGIES LLC (4.57M shares), GEODE CAPITAL MANAGEMENT, LLC (3.3M shares), AQR CAPITAL MANAGEMENT LLC (2.64M shares), NORTHERN TRUST CORP (2.49M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (2.42M shares).
This table shows the top 1080 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.